Guardant Health Nears Buy Point As Sales Outlook Brightens

Guardant Health provides services across the cancer continuum. Shares are near a buy point of 176.58 after a breakout. The post Guardant Health Nears Buy Point As Sales Outlook Brightens appeared first on Investor's Business Daily.